PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial.
暂无分享,去创建一个
K. Flaherty | J. Sosman | A. Ribas | M. Lacouture | P. Chapman | G. McArthur | K. Nolop | Richard J Lee | M. Duvic | K. Kim